Oxaliplatin HAI

DRUG2 trials

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris, Sun Yat-sen University

Conditions

Colorectal CancerLiver MetastasesMetastatic Colorectal Cancer

Phase 2

Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases

CompletedNCT02494973

Gustave Roussy, Cancer Campus, Grand ParisColorectal Cancer

Start: 2015-05-26End: 2024-03-18Updated: 2024-10-28

Phase 3

FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

TerminatedNCT03678428

Sun Yat-sen UniversityLiver Metastases, Metastatic Colorectal Cancer

Start: 2021-12-31End: 2022-12-31Updated: 2023-02-16

Related Papers

Postoperative hepatic arterial chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: A multicenter randomized phase II trial (PRODIGE 43 - PACHA-01).

Journal of Clinical Oncology2023-06-019 citations

Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).

2018-08-0625 citations